1. Home
  2. BLBD vs NRIX Comparison

BLBD vs NRIX Comparison

Compare BLBD & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blue Bird Corporation

BLBD

Blue Bird Corporation

HOLD

Current Price

$57.79

Market Cap

1.7B

ML Signal

HOLD

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$15.96

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLBD
NRIX
Founded
1927
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
BLBD
NRIX
Price
$57.79
$15.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
13
Target Price
$67.20
$29.46
AVG Volume (30 Days)
495.0K
716.8K
Earning Date
05-11-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
22.78
N/A
EPS
0.94
N/A
Revenue
$1,480,099,000.00
$76,987,000.00
Revenue This Year
$4.25
N/A
Revenue Next Year
$4.21
$29.30
P/E Ratio
$61.82
N/A
Revenue Growth
9.87
99.31
52 Week Low
$30.15
$8.18
52 Week High
$62.90
$22.50

Technical Indicators

Market Signals
Indicator
BLBD
NRIX
Relative Strength Index (RSI) 53.02 43.33
Support Level $53.58 $15.22
Resistance Level $58.57 $16.49
Average True Range (ATR) 2.53 0.74
MACD -0.32 0.07
Stochastic Oscillator 28.48 40.49

Price Performance

Historical Comparison
BLBD
NRIX

About BLBD Blue Bird Corporation

Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments; the Bus segment which involves the design, engineering, manufacture, and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Rest of the world.

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.

Share on Social Networks: